Diligence memo · auto-generated · as of July 2, 2026
Emerald Therapeutics, Inc.
Emerald Therapeutics, Inc. looks fair against its niche peers and is dormant on financing cadence.
Businessfiled
Emerald Therapeutics, Inc. operates in Other Health Care, based in MENLO PARK.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Emerald Therapeutics, Inc. has raised $15M in disclosed capital across 4 recorded rounds, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).
Largest single filing: $5.6M on 2014-02-07.
Most recent recorded round closed around 2014-02-07.
Valuation (modeled)modeled
Provath models Emerald Therapeutics, Inc. at approximately $113M (range $7.2M–$616M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 0.94× the median modeled value of Series A Other Health Care companies in 2013–2015 (187 peers) — value vs value, same stage and era. Within the normal band (94% of peer median) for its niche.
Financing rhythm & timingmixed
Historic cadence: a new round about every 14 months.
Last raise 12.4 yr ago; this sector typically re-raises about every 14 months.
Silent for over 3× the sector's normal cadence.
The last round stepped up 5.6× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 81% of Other Health Care peers (5377 compared).
Modeled value ranks above 81% of those peers.
Closest niche peers: Imagine Health, Inc., Spruce Health, Inc., Inova Labs, Inc., Cephea Valve Technologies, Inc., ClarVista Medical, Inc..
Peoplefiled
7 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.